• English
  • Español

Sesión de Pósteres 3

Sesión de Pósteres 3
Sábado 22 Octubre 11, 10:30-11:15h

Knowledge translation and communicating evidence (P3A272-P3A332)

Knowledge translation and communicating evidence (P3B333-P3B345)

Statistical methods (P3B346-P3B381)

Consumer issues and shared decision making (P3B382-P3B400)

 

LatinCLEN Sesión de Pósteres 2
Sábado 22 Octubre 11, 10:30-11:15h

 

 

Knowledge translation and communicating evidence (P3A272-P3A332) – (Vestíbulo 1er piso)

●         P3A272: What kind of evidence can be found in incident reporting systems? Systematic evaluation of incident reports to identify risks using syringe pumps. Rohe J, Hahnenkamp C, Dichtjar T, Sangiuno HA, Thomeczek C, Schleppers A.

●         P3A273: How to obtain NNT from Cohen’s d: comparison of two methods. Furukawa TA, Leucht S.

●         P3A274: Development of a methodological framework for systematic review-based evidence briefings. Chambers D, Wilson P.

●         P3A275: Cochrane reviews: beyond implications for research.González U.

●         P3A276: Building a database of validated pediatric outcomes. Adams D, Sivakumar L, Nasser H, Surrette S, Hartling L, Vohra S.

●         P3A277: Patient values and preferences for decision making in antithrombotic therapy: a systematic review. MacLean S, Mulla S, Jankowski M, Akl E, Vandvik P, Ebrahim S, McLeod S, Bhatnagar N, Guyatt G.

●         P3A278: Publication of IPD meta-analyses in the Cochrane Database of Systematic Reviews: potential barriers and opportunities. Rydzewska L, Tierney J, Clarke M, Stewart L, Rovers M.

●         P3A279: The strategies and measures of improvement of the quality of clinical trials in China. Wu T, Li Y.

●         P3A280: Investigating determinants of experts’ judgement on appropriateness for diagnostic tests when using the “Grading of Recommendations Assessment, Development and Evaluation (GRADE)” method for resenting evidence. Ballini L, Negro A, Vignatelli L, Maltoni S, Grilli R.

●         P3A281: Evidence-based guidelines in a teaching primary care health service: the beginning of evidence-based medicine in the Amazonian region. Andriolo RB, Silva BNG, Atallah N.

●         P3A282: Characteristics of studies included for HTA reports. Wolff R, Ravaud P, Liberati A, Bonfill X, Antes G.

●         P3A283: How many evidence based guidelines in China.Yang K, Chen Y, Yao L, Liang H, Wang Z, Xiao X, Wang Q.

●         P3A284: Evaluating the feasibility of interventions for use within NHS mental health services. Bird V, Leamy M, Le Boutillier C, Williams J, Slade M.

●         P3A285: Logic model as a knowledge translation tool for complex interventions in systematic reviews. Augustincic Polec L, Ueffing E, Welch V, Tanjong Ghogomu E, Pardo Pardo J, Grabowsky M, Attaran A, Tugwell P.

●         P3A286: Systematic review of clinical practice guidelines and consensus statements about living kidney donation. Tong A, de Bruyn J, Wong G, Chapman J, Craig J.

●         P3A287: Chinese Cochrane Database of Systematic Reviews of Cochrane Library: a nationwide survey of utilization in Taiwan. Chiu YW, Wen YH, Kuo KN.

●         P3A288: Uptake of Cochrane Acute Respiratory Infections reviews in primary care guidelines. Van Driel M, Thorning S, Dooley L, van der Wouden H.

●         P3A289: Scoring trials on the efficacy-effectiveness continuum – a systematic analysis. Witt C, Manheimer E, Lüdtke R, Hammerschlag R, Lao L, Berman B.

●         P3A290: Interactive tools to teach the public to be critical consumers of information about health care: What’s out there? Krause LK, Schwartz L, Woloshin S, Oxman A.

●         P3A291: Partnership to improve health research reporting in Spanish-speaking countries-especially Latin America and Caribbean. Villanueva E, Simera I, Cuervo LG, Altman D, Moher D, Reveiz L.

●         P3A292: Evidence-based practice in first aid and prevention guidelines of Belgian Red Cross-Flanders. Pauwels NS, Dieltjens T, Van de Velde S, De Buck E.

●         P3A293: How evidence-based are the pharmaceutical industry’s printed promotional material presented to physicians in three Latin American countries. Ciapponi A, Reveiz L, Glujovsky D, García Martí S, Rey Ares L, Bardach A, Ramírez Moreno L, Ferreira AM, Rubinstein F, Rada G.

●         P3A294: Strategies to reduce attrition in randomised trials: a methodology review. Brueton V, Tierney J, Stenning S, Nazareth I, Meredith S, Harding S3, Rait G.

●         P3A295: Do the European clinical guidelines recommend evidence based interventions for drug addiction? A benchmark exercise. Ferri M, Bo A, Allara E.

●         P3A296: Progress in time to update of Cochrane systematic reviews. Ngamjarus C, Jaidee W, Laopaiboon M.

●         P3A297: Bringing evidence into practice: use of a rapid review methodology to formulate medical recommendations for the Red Cross Blood Service. De Buck E, Van de Velde S, Dieltjens T, Vandekerckhove P.

●         P3A298: Deficient Reporting and Interpretation of Non-Inferiority Clinical Trials In Antiretroviral-naïve HIV Patients: A Systematic Review. Hernandez AV1, Pasupuleti V1, Deshpande A, Collins JA, Vidal JE.

●         P3A299: Setting priorities for comparative effectiveness research on the management of primary angle closure (PAC): A survey of Asia-Pacific clinicians. Yu T, Li T, Puhan M, Dickersin K.

●         P3A300: Course “Hot topics in pharmacotherapy”: a way to disseminate evidence. Garjón Parra J, Erviti López J, Azparren Andía A, Gorricho Mendívil J, López Andrés A.

●         P3A301: Do systematic reviews within EPOC contain sufficient information about effect and enough information about the intervention to make informed policy decisions? Holte HH.

●         P3A302: How and when to pool data in meta-analyses to make the results clinically meaningful. Ringerike T, Klemp M.

●         P3A303: Long-term harm and memory impairment in electroconvulsive therapy treatment for depression – preliminary results from a systematic review with integrative methodological approach. Leiknes KA, Høie B, Jarosch-von Schweder L, Berg R, Smedslund G.

●         P3A304: Use of indirect comparison methods in systematic reviews: a survey of Cochrane review authors’ views. Abdelhamid A, Loke YK, Parekh S, Chen Y, Sutton A, Eastwood A, Holland R, Song F.

●         P3A305: Generation of quality of care indicators based on systematic reviews. Osorio D, Aller M, Roqué M, Foradada C, Vives A, Rigau D, Bonfill X.

●         P3A306: Graphic display for effective reporting of evidence quality tables.Khan K, Mignini L, Borowiack E, Ross C, Kowalska M, Zapalska A, Mol B, Meads C, Walczak J.

●         P3A307: Mapping research gaps in interventions related with the Millennium Development Goal (MDG) 5-A (maternal mortality) in the “implication for research” section of Cochrane reviews.Higgins V, Chapman E, Reveiz L, Cuervo LG.

●         P3A308: A Citation Analysis of Cochrane systematic reviews in Chinese Science Citation Database. Chen Y, Wei D, Li J, Xu H, Zhu S.

●         P3A309: A systematic review of the quality and types of instruments used to assess KTE implementation and impact. Irvin E, Cole D, Keown K, Kramer D, Brenneman Gibson J, Kazman Kohn M, Mahood Q, Slack T, Amick III B, Phipps D, Garcia J, Morassaei S.

●         P3A310: The impact of systematic reviews on health care policy. Frances Bunn.

●         P3A312: Determining the role of patient values and preferences in the development and review of preference-sensitive practice guidelines. MacLean S, Akl E, Johnston B, Guyatt G.

●         P3A313: A US hospital-based health technology assessment center to improve the quality, safety and cost-effectiveness of patient care. Mitchell M, Williams K, Umscheid C.

●         P3A314: Simple ‘quick’ searches to answer questions arising in clinical practice. Jordan J, Stevenson K, Lewis R.

●         P3A316: Effectiveness of quality improvement strategies to improve the management of diabetes: Systematic review and meta-regression. Tricco A, Ivers N, Moher D, Turner L, Galipeau J, Halperin I, Vachon B, Ramsay T, Manns B, Tonelli M, Shojania K, Grimshaw J.

●         P3A317: Exploring the experiences with a new policy for managing conflict of interest in guideline developers. Neumann I, Akl E, Guyatt G.

●         P3A318: Judiciary branch and scientific evidence: an analysis of judicial decisions on galsufase. Marin dos Santos D, Atallah A, Dallari Jr. H, Barroso L.

●         P3A319: High impact collaborations: Examples from the Cochrane HIV/AIDS Group. Horvath T, Kennedy GE, Rutherford GW.

●         P3A320: Do Cochrane reviews inform the development of clinical practice guidelines? The case of hypertension. Al-Ansary L, Tricco A, Adi Y, Al-Ghonaim M, Bawazeer G, Perrier L, Tashkandi M, Straus S.

●         P3A321: Impact of an evidence based pediatrics electronic journal. González MP, Buñuel JC, González de Dios J, Esparza MJ, Aizpurua P.

●         P3A322: Do Cochrane reviews drive clinical decision-making at the point of care? Moja L, Banzi R, Cinquini M, Moschetti I, Pecoraro V, Tagliabue L, Liberati A.

●         P3A323: Mr. Pickwick and his child went on a field trip and returned empty handed: the widening gap between non-randomised studies and evidence for circadian rhythm sleep disorders management in a paediatric population. Khan S, Heussler H, McGuire T, Pache D, Dakin C, Cooper D, Norris R, Flenady V, Charles B.

●         P3A324: Including diverse study types in systematic reviews to address multiple questions about public health interventions: the case of a review of school effects on health. Harden A, Bonell C, Jamal F, Wells H.

●         P3A325: Measuring organizational readiness for knowledge translation in chronic care: a mixed methods systematic review on theories and instruments. Gagnon M, Légaré F, Ouimet M, Estabrooks CA, Roch G, Labarthe J, Ghandour EK, Tremblay N, Grimshaw J.

●         P3A326: Use of Cochrane reviews in NICE clinical guidelines. Alderson P, Tan T.

●         P3A327: Developing a web-based international register of clinical prediction rules for primary care. Keogh C, Wallace E, Fahey T.

●         P3A328: Synthesis of recommendations for clinical use of biomarkers in oncology. Trevisiol C, Pregno S, Rosin C, Fabricio ASC, Gion M.

●         P3A329: Collaborative Knowledge Networks (CKN) for guideline development: a Kaiser Permanente and BMJ Evidence Centre case study. Davino-Ramaya MD C, Brunnhuber MD K, Haynes MPH J, Simpkins MD C, Tom MS G, Minhas MB ChB R, Robbins MD C.

●         P3A330: Reporting Guidelines for Systematic Review Protocols. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart L.

●         P3A331: An extrapolation checklist to answer “Can I use the results of this systematic review in a disadvantaged population? Ueffing E, Petticrew M, Welch V, Clarke M, Gruen R, Guyatt G, Kristjansson E, Mercer S, Pardo Pardo J, Tugwell P.

●         P3A332: Systematic Review of the Impact of Reporting Guidelines on publication quality. Moher D, Palepu A, Shamseer L, Turner L, Altman D, Hirst A, Hoey J, Schulze K, Simera I.

 

Knowledge translation and communicating evidence (P3B333-P3B345) – (Vestíbulo 2º piso)

●         P3B333: Developing a typology of activities for linking research evidence to research use. Tripney J, Kenny C, Gough D.

●         P3B334: Agree instrument: a good instrument for family practice training. Stein AT, Khan GS.

●         P3B335: Access to The Cochrane Library: results of Canada’s national pilot license initiative. Squires J, Grimshaw J, Schaafsma ME.

●         P3B336: Do value judgments play a role in evidence-based recommendations when information is based on proof of concept? Hutton B, Lee K, O’Grady T, Shukla V.

●         P3B337: Proof of value decisions from proof of concept data: a review of Canadian formulary review recommendations. Shukla V, O’Grady T, Clifford T, Hutton B.

●         P3B339: Resource use compared to evidence of effectiveness as an indirect measure of clinical quality and a basis for improvement. Harris J

●         P3B340: A Canadian example of facilitating the uptake of syntheses into public health practice. Docorby K, Tirilis D, Husson H, Robeson P, McCrae L, Greco L.

●         P3B341: Bringing Best Evidence to Front Line Clinicians. Tejani A, Adlparvar C.

●         P3B342: Evidence to support process improvement: what’s available, and how to proceed. Harris J.

●         P3B343: Cochrane Journal Club: going from strength to strength? Curtis T.

●         P3B344: Who is listening? – A qualitative study of Cochrane podcast users. Stewart G, Mavergames C.

●         P3B345: Cochrane review of school-based interventions for the prevention of human immunodeficiency virus (HIV) and sexually transmitted infections (STIs) in adolescents: Why biological outcomes are important. Mason-Jones A, Mathews C, Kagee A, Lombard C.

 

Statistical methods (P3B346-P3B381) – (Vestíbulo 2º piso)

●         P3B346: Trial Sequential Analyses of Meta-analyses from a Cochrane Review of Targeting Intensive versus Conventional Glycaemic Control in Patients with Type 2 Diabetes. Hemmingsen B, Lund S, Gluud C, Vaag A, Almdal T, Hemmingsen C, Wetterslev J.

●         P3B347: A comparison of subgroup analyses in grant applications and publications. Boonacker CW, Hoes AW, van Liere - Visser K, Schilder AG, Rovers MM.

●         P3B348: The impact of underpowered studies in meta-analyses reported by Cochrane reviews. Turner R, Bird S, Higgins J.

●         P3B349: Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. Bowden J, Tierney J, Copas A, Burdett S.

●         P3B350: Individual participant data meta-analysis of prognostic factor studies: state of the art? Riley R, Abo-Zaid G, Sauerbrei W.

●         P3B351: The effect of the assessment goal on the interpretation of subgroup findings and the corresponding conclusions. Bender R.

●         P3B352: Exploring treatment by covariate interactions in mixed treatment comparison meta-analysis: individual patient-level covariates versus aggregate trial-level covariates. Donegan S , Williamson P, D’Alessandro U, Tudur-Smith.

●         P3B353: Is it reasonable to pool estimates of intervention effect estimated from different analytical methods for continuous outcomes? A meta-epidemiological study. McKenzie JE, Deeks JJ.

●         P3B354: IPD meta-analysis of time-to-event data: one-stage versus two-stage approaches to estimating the hazard ratio. Bowden J, Tierney J, Simmonds M, Copas A, Higgins J.

●         P3B355: The use of an ordered multinomial logit model in network analysis: an example in psoriatic arthritis. Craig D, Epstein D, Yang H, Bojke L, Sculpher M, Woolacott N.

●         P3B356: Classification of Methods for Evaluation of Treatment Selection Markers: A Systematic Review. Tajik P, Mol BW, Bossuyt PM.

●         P3B357: Adverse events of antiepileptic drugs, across indications: Can randomised controlled trial data from non-epilepsy indications be included in meta-analysis for AEDs used in epilepsy? Tudur-Smith C, Marson A.

●         P3B358: Exploring the effects of different treatment doses by ‘blurring’ the nodes of a treatment network: application to a Cochrane overview for multiple sclerosis. Del Giovane C, Mavridis D, Vacchi L, Filippini G, Salanti G.

●         P3B359: Meta-analysis of diagnostic studies: SROC modelling - the profile log-likelihood approach based upon the proportional hazard model. Charoensawat S, Böhning D.

●         P3B360: How to improve the credibility of meta-analysis? How to avoid mistakes in choosing the statistical method of estimation? The Bayesian and traditional approaches. Nikodem M, Walczak J, Borowiack E, Siedmiogrodzki K, Zapalska A, Khan K, Meads C, Mol B, Oude Rengerink K, Thangaratinam S, Zamora J.

●         P3B361: Meta-analytical approaches for diagnostic and prognostic prediction research: incorporating published univariable associations in multivariable analysis of individual patient data. Debray T, Koffijberg H, Lu D, Vergouwe Y, Steyerberg EW, Moons KGM.

●         P3B362: Aggregating published prediction models with individual patient data: a comparison of different approaches. Debray T, Koffijberg H, Vergouwe Y, Steyerberg EW, Moons KGM.

●         P3B363: Comparison of results from different imputation techniques of missing data in an anti-obesity drug trial. Jørgensen AW, Lundstrøm LH, Wetterslev J, Astrup A, Gøtzsche PC.

●         P3B364: Individual participant data meta-analyses compared with meta-analyses based on aggregate data. Tudur Smith C, Marcucci M, Rovers M, Riley R, Oyee J, Iorio A, Williamson P, Clarke M.

●         P3B365: Meta-analysis of treatment by patient subgroup interactions using summary data: a case study and suggestions for future practice. Fisher D, Tierney J, Vale C, Copas A, Parmar M.

●         P3B366: Re-analysis of meta-analyses in Cochrane reviews using robust statistical methods. Smedslund G, Mowinckel P

●         P3B367: Meta-analysis of ordinal outcome measures in stroke trials - can we do better? Weir J, Lewis S, Sandercock P, Thomas B, Murray G.

●         P3B368: Issues affecting the validity of a network meta-analysis of acupuncture and other physical therapies for the relief of chronic pain due to osteoarthritis of the knee. Rice SJC, Woolacott NF, Corbett MS, Slack R.

●         P3B369: Imputing 2x2 contingency tables from odds ratios: difficulties, constraints and impact in metaanalysis results. Veroniki AA, Patsopoulos N, Pavlides M, Salanti G.

●         P3B370: Predicting the need to update a systematic review. Takwoingi Y, Hopewell S, Sutton A, Marshall R, Tovey D.

●         P3B371: Feasibility of establishing a central repository for the individual participant data from research studies. Altman D, Clarke M, Dwan K, Riley R, Williamson P.

●         P3B372: The hazards of extracting hazard ratios from survival curves for meta-analyses in observational studies. Imamura M, MacLennan S, Dahm P, Neuberger MM, Omar MI, MacLennan G.

●         P3B373: Standardized mean differences may be used to derive odds ratios of treatment response: meta-epidemiological study. Da Costa BR, Rutjes AWS, Johnston BC, Reichenbach S, Nüesch E, Guyatt G, Jüni P.

●         P3B374: Likelihood approach to evaluating evidence in meta-analysis. Assam P, Chan E.

●         P3B375: Interpreting pooled estimates in systematic reviews involving continuous variables. Thorlund K, Johnston B, Furukawa T, Patrick D, Schunemann H, Walter S.

●         P3B376: Calculation of variance of treatment effects when these are not reported for all arms of trials with more than two arms. Cates C, Karner C.

●         P3B377: Minimal important difference in meta-analyses: applying anchor-based and distribution-based methods to increase precision. Johnston B, Thorlund K, da Costa B, Furukawa T, Guyatt G.

●         P3B378: The calculation of hazard ratios from data published in reports of randomised controlled trials; are they valid? Glenny A, Furness S, Worthington H.

●         P3B379: When do indirect and mixed treatment comparisons result in invalid findings? A graphical explanation. Jansen JP, Schmid C, Salanti G.

●         P3B380: Flexible models for network meta-analysis of survival data. Jansen JP.

●         P3B381: Exploring indirect effects of comparative effectiveness in a Cochrane review. Wolf F, Devine B, Nguyen H.

 

Consumer issues and shared decision making (P3B382-P3B400) – (Vestíbulo 2º piso)

●         P3B382: From Patient to Advocate. Ford P.

●         P3B383: Evidence, Evidence Gaps, and the Consumer Viewpoint: Lessons from the US Mammography Guidelines. Johnson L, Wale J.

●         P3B384: Different conclusions drawn from same topic: what and why? Tian J, Liu A, Yang K, Li L.

●         P3B385: How to build evidence network of interventional studies? Li L, Sun T, Han D, Tian J, Yang K.

●         P3B386: Dissemination of the Cochrane reviews: a national survey among the regional hospitals in Taiwan. Chiu YW, Weng YH, Shih YH, Lo HL, Kuo KN.

●         P3B387: Shared decision-making interventions for children with chronic conditions: determining the clarity of the evidence. Sutcliffe K.

●         P3B388: Consumer Support and education beyond national borders: A case study. Walsh M, Rader T.

●         P3B389: Incorporating patients’ perspectives in hospital-based health technology assessment (HTA): The views of HTA producers, hospital managers and patients. Gagnon M, Desmartis M, Lepage-Savary D, Gagnon J, St-Pierre M, Rhainds M, Lemieux R, Gauvin F, Légaré F.

●         P3B390: A Bibliometric Analysis of Cochrane collaboration and its products. Chen Y, Xiao X, Wang Z, Yao L, Yang K.

●         P3B391: Evidence-based medicine and the right to health: economic and legal sustainability. Marin dos Santos D, Atallah A, Riera R, Silva E.

●         P3B392: Treatment information-seeking by people with multiple sclerosis in the internet age: Stage 1 findings of the IN-DEEP project. Hill S, Filippini G, Summers M, Beecher D, Synnot A, Mosconi P, Shapland S, Colombo C, Baroni I, Osborne R, Traversa S.

●         P3B393: Cochrane CENTRAL & CAFÉ (Communication Access Framework and Evidence): Locating intervention studies on clinical communication for communicatively vulnerable populations. Hemsley B, Worrall E, Kis-Rigo J, O’Halloran R, Hill S.

●         P3B394: Are claims made in advertisements of nutritional supplements in South African women’s magazines supported by research evidence? Schoonees A, Volmink J.

●         P3B395: Behind the dementia headlines – a systematic look at the quality of reporting of dementia research in two UK national newspapers. Noel-Storr A1, Struthers C, Marcus S.

●         P3B396: Social relevance of Evidence-based medicine in the Brazilian drug market. Marin dos Santos D, Barroso L, Atallah A, Silva E.

●         P3B397: Giving Brazilian women access to evidence based information in Portuguese: the translation of Pregnancy and Childbirth Group PLS. Audebert Delage Silva DR, Grilo Diniz CS, Mulheres em Rede pela Maternidade Ativa PDP.

●         P3B398: Selective publication of clinical trials and legal response: the right to health and information. Marin dos Santos D, Atallah A, Dallari Jr. H, Bartomolei C.

●         P3B399: Evidence-based civil action: the case of the Brazilian ‘Companion Law’. Audebert Delage Silva DR, Kondo C, Grilo Diniz CS, Mulheres em Rede pela Maternidade Ativa PDP.

●         P3B400: The Cochrane Library for Consumers – a new website (beta). McIlwain C, Mavergames C.

 

 

LatinCLEN Sesión de Pósteres 2 – (Vestíbulo 2º piso)
Sábado 22 Octubre 11, 10:30-11:15h

●         L11: Sensibilidad al estrés y trastornos de la conducta alimentaria: Un modelo de asociación. Sergio Muñoz, Rosa Behar, Patricia Cordella, Karina Jaramillo, Manuel Ortiz y Jaime R. Silva.

●         L12: Efectividad del apoyo social en la recuperación funcional, afrontamiento y calidad de vida del paciente con discapacidad secundaria a EVC en el IMSS. Alberto Peréz Rojas, Laura del Pilar Torres Arreola, Sonia Patricia de Santillana.

●         L13: Efectividad del tratamiento del Síndrome Déficit Atencional en Chile. Mónica Velásquez, Carlos Vallejos, Patricio Valdés, Roberto Reveco, Sergio Puebla.

●         L14: Validación de un Cuestionario de Frecuencia de Consumo de Alimentos en el Cono Sur de Latinoamérica. Natalia Elorriaga, Gabriela Cormick, Monica Britz, Solange Martínez, Rocío Suárez, Vilma Irazola, Adolfo Rubinstein.

●         L15: Sistema de Identificación de Documentos Medico-Asistenciales de un Hospital. Barcelona – España. 2011. Mónica Chirinos, Teresa Puig, Nuria Lluis, Xavier Bonfill,

●         L16: Prevalência de Depressão e qualidade de vida dos pacientes renais crônicos em hemodiálise na região de Marília - São Paulo / Brasil. Ricardo Correa Ferreira, Carlos Rodrigues da Silva Filho, Lucieni de Oliveira Conterno.

●         L17: Mejora de la adecuación de la práctica asistencial y clínica en el Hospital de la Santa Creu i Sant Pau de Barcelona. M Jesús Quintana, Teresa Puig, Núria Lluís, Ignasi Bolíbar, Ignasi Gich, . Ivan Solà, Gerard Urrútia, Xavier Bonfill.

●         L18: FSH humana altamente purificada frente a la FSH recombinante en la reproducción humana asistida. Martínez-Zapata MJ, Vázquez J, Roqué M, Solà I, Urrútia G.

●         L19: Valores de referencia para la Calidad de vida en Medellín (Colombia) con el Cuestionario de Salud SF-36. Héctor García, Luz Lugo, Claudio Vera.